Service agreement facsaria III - 5 laser system
Active Awarded Last action
- Contract number
- 75N92024F00076
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $102,132
Award facts
- Opportunity
-
- 75N92024Q0961 Solicitation number
- Contract value 100% obligated
- $102,132.36 Current and potential, with all options
- Completion date 86% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $34,044 | |
| Exercise an Option | $34,044 | |
| Original award | $34,044 |
About this award
Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a delivery order award from the National Heart, Lung, and Blood Institute (NHLBI) on April 1, 2024, for a Service Agreement covering a FACSAria III 5-laser flow cytometry system. This firm fixed-price delivery order, with a ceiling value of $102,132.36 and ultimate completion date of March 31, 2027, was issued without a set-aside designation and represents a task order against the Multiple Award Schedule (MAS) procurement vehicle. The work will be performed at the NHLBI facility in Bethesda, Maryland. BD Biosciences is a leading supplier of advanced flow cytometry instruments and associated maintenance services to federal biomedical research and clinical diagnostic operations, with the FACSAria platform being a core component of its federal product portfolio.
This delivery order supports NHLBI's biomedical research infrastructure by providing specialized flow cytometry instrumentation essential for cell analysis, sorting, and immunological research applications. BD Biosciences maintains established relationships with multiple NIH components, including prior contract awards from the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and other NIH institutes, for comparable flow cytometry systems, reagents, and comprehensive technical support services. The company's federal contracting experience and established capability as a sole-source supplier for specialized laboratory instrumentation positions it to deliver the technical requirements of this system procurement within the performance period.
Quick answers
Who was awarded contract 75N92024F00076?
75N92024F00076 was awarded to Becton, Dickinson And Company by National Heart Lung and Blood Institute (National Institutes of Health) on April 1, 2024.
How much is contract 75N92024F00076 worth?
The government has obligated $102,132 on 75N92024F00076.
Is contract 75N92024F00076 an order under another contract?
Yes. 75N92024F00076 is a delivery order under GS07F195DA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75N92024F00076 competed?
The extent of competition for 75N92024F00076 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award